InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: None

Wednesday, 02/10/2021 10:48:33 AM

Wednesday, February 10, 2021 10:48:33 AM

Post# of 42810
Today's drop is probably because of Eli Lilly getting an EUA for its mab cocktail. Eli Lilly's drug is for moderate cases so it isn't in competition with lenzilumab. But a lot of investors don't know the difference. This is a nice opportunity for people to buy sub-$21. It will likely be the last time it is possible.